Swiss WorldCargo has received IATA’s Center for Independent Validators (CEIV) Pharma certification encompassing the airline.
The certification was awarded following an extensive review from IATA recognised independent auditors. The certification means that IATA now recognises the airline’s “globally consistent pharmaceutical handling and processes” to maintain standards.
Swiss WorldCargo’s Zurich hub received CEIV certification in 2016, and is also recognised as GDP compliant by Swiss authorities Swissmedic.
Alexandre de Juniac, IATA’s Director General and CEO handed over the certificate to Michael Niggemann, chief financial officer and member of management board of Swiss International Air Lines. Swiss WorldCargo said it would continue to develop its “pharma road-map” to improve its footprint in the isegment of pharmaceuticals and life sciences.
Previously, Swiss WorldCargo was the first company to establish the so-called “quality corridors,” or dedicated pharma traffic lanes between select destinations, that offer safe pharmaceutical shipments from airport to airport.
Swiss WorldCargo is the airfreight division of Swiss International Air Lines (SWISS). Headquartered at Zurich Airport, Swiss WorldCargo offers a comprehensive range of logistics solutions for transporting high-value and care-intensive consignments to some 130 destinations in over 84 countries.